SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-137599
Filing Date
2011-05-12
Accepted
2011-05-12 16:14:29
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 434509
2 MASTER SERVICES AGREEMENT dex102.htm EX-10.2 92140
3 FIRST AMENDMENT TO MASTER SERVICES AGREEMENT dex103.htm EX-10.3 11892
4 AMENDED AND RESTATED COLLABORATION AGREEMENT dex104.htm EX-10.4 324477
5 LICENSE AGREEMENT dex105.htm EX-10.5 482021
6 TERMINATION AND TRANSITION AGREEMENT dex106.htm EX-10.6 63250
7 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 10029
8 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 10414
9 CERTIFCATION OF CEO AND CFO PURSUANT TO 13A-14(B) OR 15D-14(B) dex321.htm EX-32.1 5752
10 GRAPHIC g185338g43r42.jpg GRAPHIC 11021
  Complete submission text file 0001193125-11-137599.txt   1450980
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 11835978
SIC: 2834 Pharmaceutical Preparations